Judy M. Moreau

953 total citations
19 papers, 797 citations indexed

About

Judy M. Moreau is a scholar working on Ophthalmology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Judy M. Moreau has authored 19 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Ophthalmology, 9 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Judy M. Moreau's work include Ocular Infections and Treatments (17 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Bacterial biofilms and quorum sensing (6 papers). Judy M. Moreau is often cited by papers focused on Ocular Infections and Treatments (17 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Bacterial biofilms and quorum sensing (6 papers). Judy M. Moreau collaborates with scholars based in United States. Judy M. Moreau's co-authors include Richard J. O’Callaghan, James M. Hill, Emma B.H. Hume, Lawrence S. Engel, Armando R. Caballero, Lee S. Engel, Michelle C. Callegan, Timothy J. Foster, Gregory D. Sloop and Mary E. Marquart and has published in prestigious journals such as Analytical Biochemistry, Infection and Immunity and American Journal of Ophthalmology.

In The Last Decade

Judy M. Moreau

19 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judy M. Moreau United States 14 363 322 235 183 109 19 797
Armando R. Caballero United States 19 579 1.6× 389 1.2× 182 0.8× 222 1.2× 97 0.9× 52 1.1k
R. Karthikeyan India 11 162 0.4× 215 0.7× 73 0.3× 94 0.5× 108 1.0× 22 480
Abirami Kugadas United States 12 182 0.5× 260 0.8× 52 0.2× 264 1.4× 133 1.2× 26 683
Holly Hamilton United States 15 628 1.7× 47 0.1× 126 0.5× 63 0.3× 95 0.9× 32 1.2k
Elly Cheng United States 13 151 0.4× 126 0.4× 303 1.3× 73 0.4× 144 1.3× 20 747
L D Gray United States 11 216 0.6× 45 0.1× 65 0.3× 114 0.6× 206 1.9× 14 767
Andreas Obwaller Austria 15 425 1.2× 168 0.5× 79 0.3× 111 0.6× 98 0.9× 26 1.0k
Pauline Yoong United States 17 758 2.1× 32 0.1× 698 3.0× 154 0.8× 267 2.4× 19 1.3k
Viviane Finck‐Barbançon United States 11 870 2.4× 55 0.2× 584 2.5× 182 1.0× 243 2.2× 16 1.4k
Mahmoud Ghannoum United States 15 168 0.5× 50 0.2× 473 2.0× 64 0.3× 107 1.0× 38 921

Countries citing papers authored by Judy M. Moreau

Since Specialization
Citations

This map shows the geographic impact of Judy M. Moreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy M. Moreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy M. Moreau more than expected).

Fields of papers citing papers by Judy M. Moreau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy M. Moreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy M. Moreau. The network helps show where Judy M. Moreau may publish in the future.

Co-authorship network of co-authors of Judy M. Moreau

This figure shows the co-authorship network connecting the top 25 collaborators of Judy M. Moreau. A scholar is included among the top collaborators of Judy M. Moreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy M. Moreau. Judy M. Moreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dajcs, Joseph J., Gregory D. Sloop, Judy M. Moreau, et al.. (2002). Corneal pathogenesis of Staphylococcus aureus strain Newman.. PubMed. 43(4). 1109–15. 40 indexed citations
2.
Moreau, Judy M., Emma B.H. Hume, Joseph J. Dajcs, et al.. (2002). Effectiveness of Mupirocin and Polymyxin B in Experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens Keratitis. Cornea. 21(8). 807–811. 15 indexed citations
3.
Caballero, Armando R., Judy M. Moreau, Lee S. Engel, et al.. (2001). Pseudomonas aeruginosa Protease IV Enzyme Assays and Comparison to Other Pseudomonas Proteases. Analytical Biochemistry. 290(2). 330–337. 126 indexed citations
4.
Dajcs, Joseph J., Judy M. Moreau, David W. Stroman, et al.. (2001). The effectiveness of tobramycin and Ocuflox® in a prophylaxis model of Staphylococcus keratitis. Current Eye Research. 23(1). 60–63. 9 indexed citations
5.
Dajcs, Joseph J., Judy M. Moreau, Brett A. Thibodeaux, et al.. (2001). Effectiveness of Ciprofloxacin and Ofloxacin in a Prophylaxis Model of Staphylococcus Keratitis. Cornea. 20(8). 878–880. 8 indexed citations
6.
Hume, Emma B.H., et al.. (2001). Staphylococcus corneal virulence in a new topical model of infection.. PubMed. 42(12). 2904–8. 38 indexed citations
7.
Moreau, Judy M., et al.. (2001). Phospholipase A(2) in rabbit tears: a host defense against Staphylococcus aureus.. PubMed. 42(10). 2347–54. 39 indexed citations
8.
Hume, Emma B.H., et al.. (2000). Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.. PubMed. 41(6). 1432–7. 65 indexed citations
9.
Hume, Emma B.H., Joseph J. Dajcs, Judy M. Moreau, & Richard J. O’Callaghan. (2000). Immunization with Alpha-Toxin Toxoid Protects the Cornea against Tissue Damage during Experimental Staphylococcus aureus Keratitis. Infection and Immunity. 68(10). 6052–6055. 43 indexed citations
10.
Hume, Emma B.H., et al.. (2000). Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. American Journal of Ophthalmology. 130(4). 544–544. 34 indexed citations
11.
Moreau, Judy M., et al.. (1999). Serratia marcescens keratitis: Strain-specific corneal pathogenesis in rabbits. Current Eye Research. 19(6). 525–532. 13 indexed citations
12.
Hume, Emma B.H., et al.. (1999). Clarithromycin for experimental Staphylococcus aureus keratitis. Current Eye Research. 18(5). 358–362. 10 indexed citations
13.
Sloop, Gregory D., et al.. (1999). Acute inflammation of the eyelid and cornea in Staphylococcus keratitis in the rabbit.. PubMed. 40(2). 385–91. 22 indexed citations
14.
Engel, Lawrence S., et al.. (1998). Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.. PubMed. 39(3). 662–5. 75 indexed citations
15.
Moreau, Judy M., Linda C. Green, Lee S. Engel, James M. Hill, & Richard J. O’Callaghan. (1998). Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacinand ofloxacin in a Staphylococcus keratitis model. Current Eye Research. 17(8). 808–812. 1 indexed citations
16.
Moreau, Judy M., Linda C. Green, Lee S. Engel, James M. Hill, & Richard J. O’Callaghan. (1998). Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in aStaphylococcuskeratitis model. Current Eye Research. 17(8). 808–812. 8 indexed citations
17.
Moreau, Judy M., Gregory D. Sloop, Lee S. Engel, James M. Hill, & Richard J. O’Callaghan. (1997). Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas. Current Eye Research. 16(12). 1221–1228. 39 indexed citations
18.
Engel, Lawrence S., J A Hobden, Judy M. Moreau, et al.. (1997). Pseudomonas deficient in protease IV has significantly reduced corneal virulence.. PubMed. 38(8). 1535–42. 46 indexed citations
19.
O’Callaghan, Richard J., Michelle C. Callegan, Judy M. Moreau, et al.. (1997). Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infection and Immunity. 65(5). 1571–1578. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Armando R. Caballero Breakdown of academic impact, for papers by R. Karthikeyan Breakdown of academic impact, for papers by Abirami Kugadas Breakdown of academic impact, for papers by Holly Hamilton Breakdown of academic impact, for papers by Elly Cheng Breakdown of academic impact, for papers by L D Gray Breakdown of academic impact, for papers by Andreas Obwaller Breakdown of academic impact, for papers by Pauline Yoong Breakdown of academic impact, for papers by Viviane Finck‐Barbançon Breakdown of academic impact, for papers by Mahmoud Ghannoum
Rankless by CCL
2026